Moderna’s potential vaccine generates a good immune response in elderly patients

Highlights

• The company tested its vaccine on 10 adults and 10 elderly adults
• The vaccine did not report any serious adverse events

Moderna announced on Wednesday that in an early-stage clinical trial, its potential corona virus vaccine has been able to generate a good immune response.   

Each participant received two doses. Each dose was 100 micrograms of the v....